OBJECTIVE: This study examined lifetime treatment contact and delays in treatment seeking, including rates for receipt of helpful treatment, after the onset of specific mental disorders and evaluated factors that predicted treatment seeking and delays in treatment seeking. METHODS: Data were from the Netherlands Mental Health Survey and Incidence Study-2, a nationally representative, face-to-face survey of the general population aged 18-64 (N=6,646). DSM-IV diagnoses, treatment contact, and respondents' perception of treatment helpfulness were assessed with the Composite International Diagnostic Interview 3.0. RESULTS: The proportion of respondents with lifetime mental disorders who made lifetime treatment contact ranged from 6.5% to 56.5% for substance use disorders and from 75.3% to 91.4% for mood disorders. Delays in initial treatment contact varied among persons with mood disorders (median=0 years), substance use disorders (0-4 years), impulse-control disorders (4-8 years), and anxiety disorders (0-19 years). The proportion of respondents who received helpful treatment ranged from 33.5% for substance use disorders to 69.5% for mood disorders. Men, older cohorts, and respondents with younger age at onset of the disorder generally were more likely to have no lifetime treatment contact, to have longer treatment delay, and to have not received helpful treatment. CONCLUSIONS: There was substantial variation in lifetime treatment contact and delays in initial treatment contact by mental disorder. Lifetime treatment contact, delays in treatment seeking, and receipt of helpful treatment did not vary by educational level.
OBJECTIVE: This study examined lifetime treatment contact and delays in treatment seeking, including rates for receipt of helpful treatment, after the onset of specific mental disorders and evaluated factors that predicted treatment seeking and delays in treatment seeking. METHODS: Data were from the Netherlands Mental Health Survey and Incidence Study-2, a nationally representative, face-to-face survey of the general population aged 18-64 (N=6,646). DSM-IV diagnoses, treatment contact, and respondents' perception of treatment helpfulness were assessed with the Composite International Diagnostic Interview 3.0. RESULTS: The proportion of respondents with lifetime mental disorders who made lifetime treatment contact ranged from 6.5% to 56.5% for substance use disorders and from 75.3% to 91.4% for mood disorders. Delays in initial treatment contact varied among persons with mood disorders (median=0 years), substance use disorders (0-4 years), impulse-control disorders (4-8 years), and anxiety disorders (0-19 years). The proportion of respondents who received helpful treatment ranged from 33.5% for substance use disorders to 69.5% for mood disorders. Men, older cohorts, and respondents with younger age at onset of the disorder generally were more likely to have no lifetime treatment contact, to have longer treatment delay, and to have not received helpful treatment. CONCLUSIONS: There was substantial variation in lifetime treatment contact and delays in initial treatment contact by mental disorder. Lifetime treatment contact, delays in treatment seeking, and receipt of helpful treatment did not vary by educational level.
Authors: Louisa Degenhardt; Meyer Glantz; Sara Evans-Lacko; Ekaterina Sadikova; Nancy Sampson; Graham Thornicroft; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Laura Helena Andrade; Ronny Bruffaerts; Brendan Bunting; Evelyn J Bromet; José Miguel Caldas de Almeida; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Yueqin Huang; Aimee Karam; Elie G Karam; Andrzej Kiejna; Sing Lee; Jean-Pierre Lepine; Daphna Levinson; Maria Elena Medina-Mora; Yosikazu Nakamura; Fernando Navarro-Mateu; Beth-Ellen Pennell; José Posada-Villa; Kate Scott; Dan J Stein; Margreet Ten Have; Yolanda Torres; Zahari Zarkov; Somnath Chatterji; Ronald C Kessler Journal: World Psychiatry Date: 2017-10 Impact factor: 49.548
Authors: Meredith G Harris; Alan E Kazdin; Wai Tat Chiu; Nancy A Sampson; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Jordi Alonso; Yasmin Altwaijri; Laura Helena Andrade; Graça Cardoso; Alfredo Cía; Silvia Florescu; Oye Gureje; Chiyi Hu; Elie G Karam; Georges Karam; Zeina Mneimneh; Fernando Navarro-Mateu; Bibilola D Oladeji; Siobhan O'Neill; Kate Scott; Tim Slade; Yolanda Torres; Daniel Vigo; Bogdan Wojtyniak; Zahari Zarkov; Yuval Ziv; Ronald C Kessler Journal: JAMA Psychiatry Date: 2020-08-01 Impact factor: 21.596
Authors: John Fayyad; Nancy A Sampson; Irving Hwang; Tomasz Adamowski; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Laura H S G Andrade; Guilherme Borges; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Elie G Karam; Sing Lee; Fernando Navarro-Mateu; Siobhan O'Neill; Beth-Ellen Pennell; Marina Piazza; José Posada-Villa; Margreet Ten Have; Yolanda Torres; Miguel Xavier; Alan M Zaslavsky; Ronald C Kessler Journal: Atten Defic Hyperact Disord Date: 2016-11-19
Authors: K J Wardenaar; C C W Lim; A O Al-Hamzawi; J Alonso; L H Andrade; C Benjet; B Bunting; G de Girolamo; K Demyttenaere; S E Florescu; O Gureje; T Hisateru; C Hu; Y Huang; E Karam; A Kiejna; J P Lepine; F Navarro-Mateu; M Oakley Browne; M Piazza; J Posada-Villa; M L Ten Have; Y Torres; M Xavier; Z Zarkov; R C Kessler; K M Scott; P de Jonge Journal: Psychol Med Date: 2017-02-22 Impact factor: 7.723
Authors: Susanne Brandstetter; Frank Dodoo-Schittko; Sven Speerforck; Christian Apfelbacher; Hans-Jörgen Grabe; Frank Jacobi; Ulfert Hapke; Georg Schomerus; Sebastian E Baumeister Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2017-04-29 Impact factor: 4.328
Authors: J C Stagnaro; A H Cia; H Vommaro; S Sustas; N Vázquez; E Serfaty; R C Kessler; C Benjet Journal: Epidemiol Psychiatr Sci Date: 2018-03-15 Impact factor: 6.892
Authors: Jenna M Jones; Mir M Ali; Ryan Mutter; Rachel Mosher Henke; Manjusha Gokhale; William Marder; Tami Mark Journal: J Behav Health Serv Res Date: 2018-10 Impact factor: 1.505